Security key
90400D108
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)
CUSIP: 90400D108
Q3 2016 13F Holders as of 30 Sep 2016
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 39,527,653
- Total 13F value
- $2,802,274,760
- Share change
- +2,416,235
- Put/Call ratio
- 45%
- SEC-reported price per share
- $70.94
- Number of holders
- 167
- Value change
- +$175,377,803
- Number of buys
- 89
- Number of sells
- 69
- Shares outstanding
- 98,459,627
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2016
Institutions
167
Top holders
10
RARE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2016
Previous quarter: Q2 2016
Ultragenyx Pharmaceutical Inc. SEC filings
Ultragenyx Pharmaceutical Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 90400D108
Recent filing periods:
Ownership snapshot
Top reported holders of RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Jun 2016
13F
Lead comparable stake: 5.9%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 5.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
5.9%
Capital Research Global Investors
4.9%
WELLINGTON MANAGEMENT GROUP LLP
4.3%
VANGUARD GROUP INC
2.6%
PRICE T ROWE ASSOCIATES INC /MD/
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
5.9%
|
$286,015,000
5,847,783 shares
|
— | 30 Jun 2016 |
| Capital Research Global Investors |
13F
Company
|
4.9%
|
$233,700,000
4,778,169 shares
|
— | 30 Jun 2016 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
4.3%
|
$204,844,000
4,188,184 shares
|
— | 30 Jun 2016 |
| VANGUARD GROUP INC |
13F
Company
|
2.6%
|
$126,664,000
2,589,718 shares
|
— | 30 Jun 2016 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
1.6%
|
$77,864,000
1,591,977 shares
|
— | 30 Jun 2016 |
| BlackRock Fund Advisors |
13F
Company
|
1.4%
|
$68,033,000
1,390,985 shares
|
— | 30 Jun 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2016
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
167
Shares
39,527,653
Rows available
167
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2016 vs Q2 2016 Across Filers
Q2 2016 holders
153
Q3 2016 holders
167
Holder diff
14
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 value | Q3 2016 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend